The Effects of CBD Isolate on Menstrual-Related Symptoms
Status:
Completed
Trial end date:
2021-09-23
Target enrollment:
Participant gender:
Summary
The goal of this open-label clinical trial is to compared two different doses for treating
menstrual-related symptoms in individuals who experience regular menstrual cycles (occurring
for 4-8 days every 21-28 days). The main question it aims to answer is:
(1) if there are changes in menstrual-related symptoms from baseline compared to all 3-months
of cannabidiol (CBD) isolate consumption.
Participants will complete a monthly baseline measure after they stop menstruating followed
by taking CBD twice daily (BID) for five days for three menstrual cycles and complete the
same measures. Researchers will compare 160mg of daily CBD isolate to 320mg of CBD isolate to
see if there are differential effects on menstrual-related symptoms (MRS).